Press Resease

Over-the-Counter Drugs Market - Global Industry Analysis

Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Published Date: 05-Aug-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5362 Status : Published

Global demand for over-the-counter drugs Market was valued at approximately USD 142.4 Billion in 2019, and is expected to generate revenue of around USD 223.5 Billion by end of 2026, growing at a CAGR of around 6.8% between 2020 and 2026

Description

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counter drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the over-the-counter drugs market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the over-the-counter drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the over-the-counter drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the over-the-counter drugs market on global and regional basis.

Global Over-the-Counter Drugs Market: By Product

  • Cough & Flu Products
  • Analgesics
  • Cold
  • Weight Loss Products
  • Mineral and Vitamin Supplements
  • Gastrointestinal Products
  • Ophthalmic Products
  • Skin Products
  • Others

Global Over-the-Counter Drugs Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. N95 Mask Market, 2016 – 2026 (USD Million)
    • 2.2. N95 Mask Market: Snapshot
  • Chapter 3. N95 Mask Market – Industry Analysis
    • 3.1. N95 Mask Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing trend of self-medication
      • 3.2.2. Growing patent expirations
    • 3.3. Restraints
      • 3.3.1. Concerns regarding improper diagnosis
      • 3.3.2. Issues related to substance abuse
    • 3.4. Opportunities
      • 3.4.1. Product innovation
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Product
      • 3.6.2. Market attractiveness analysis by Region
  • Chapter 4. N95 Mask Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global N95 Mask Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global N95 Mask Market –Product Analysis
    • 5.1. Global N95 Mask Market overview: by Product
      • 5.1.1. Global N95 Mask Market share, by Product, 2019 and 2026
    • 5.2. Cough & Flu Products
      • 5.2.1. Global N95 Mask Market by Cough & Flu Products, 2016 – 2026 (USD Million)
    • 5.3. Analgesics
      • 5.3.1. Global N95 Mask Market by Analgesics, 2016 – 2026 (USD Million)
    • 5.4. Culd
      • 5.4.1. Global N95 Mask Market by Culd, 2016 – 2026 (USD Million)
    • 5.5. Weight Loss Products
      • 5.5.1. Global N95 Mask Market by Weight Loss Products, 2016 – 2026 (USD Million)
    • 5.6. Mineral and Vitamin Supplements
      • 5.6.1. Global N95 Mask Market by Mineral and Vitamin Supplements, 2016 – 2026 (USD Million)
    • 5.7. Gastrointestinal Products
      • 5.7.1. Global N95 Mask Market by Gastrointestinal Products, 2016 – 2026 (USD Million)
    • 5.8. Ophthalmic Products
      • 5.8.1. Global N95 Mask Market by Ophthalmic Products, 2016 – 2026 (USD Million)
    • 5.9. Skin Products
      • 5.9.1. Global N95 Mask Market by Skin Products, 2016 – 2026 (USD Million)
    • 5.10. Others
      • 5.10.1. Global N95 Mask Market by Others, 2016 – 2026 (USD Million)
  • Chapter 6. Global N95 Mask Market - Regional Analysis
    • 6.1. Global N95 Mask Market overview: by Region
      • 6.1.1. Global N95 Mask Market share, by Region, 2019 and 2026
    • 6.2. North America
      • 6.2.1. North America N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.2.2. North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.2.3. U.S.
        • 6.2.3.1. U.S. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.3.2. Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.3. UK
        • 6.3.3.1. U.K. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.4.2. Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.5.2. Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.6.2. The Middle East and Africa N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. GlaxoSmithKline (GSK)
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Usage Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Sun Pharmaceutical Industries Ltd.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Usage Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Bayer HealthCare
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Usage Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Johnson & Johnson
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Usage Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Pfizer
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Usage Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Sanofi
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Usage Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Alkem Laboratories Limited
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Usage Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Glenmark Pharmaceuticals Ltd.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Usage Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Cipla, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Usage Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Takeda
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Usage Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Teva Pharmaceutical Industries Ltd.
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Usage Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. Reckitt Benckiser Group Plc
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Usage Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Innovus Pharmaceutical Inc.
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Usage Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Piramal
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Usage Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. Dr. Reddy's Laboratories
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Usage Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development

Methodology


Frequently Asked Questions

According to the report, global demand for over-the-counter drugs market was valued at approximately USD 142.4 Billion in 2019, and is expected to generate revenue of around USD 223.5 Billion by end of 2026, growing at a CAGR of around 6.8% between 2020 and 2026.

North America will be the foremost region during the estimate period. Ease of availability, sale of higher quality products and existence of top market players will enhance the market growth in this region. Europe will be the second largest market.

The report also includes detailed profiles of key players such as GlaxoSmithKline (GSK), Sun Pharmaceutical Industries Ltd., Bayer HealthCare, Johnson & Johnson, Pfizer, Sanofi, Alkem Laboratories Limited, Glenmark Pharmaceuticals Ltd., Cipla, Inc., Takeda, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc, Innovus Pharmaceutical Inc., Piramal, and Dr. Reddy's Laboratories among others.

Factors such as increasing trend of self-medication, growing patent expirations, cost saving of people in developing regions, prescription to over the counter shift by pharmaceutical companies, convenience of purchasing over the counter medicines, high demand from emerging countries, advantageous regulatory structure, and increasing awareness due to availability of information on the web will act as major driving factors in the growth of global over-the-counter drugs market.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social